Lene Maria Ørts
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Lene Maria Ørts has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
Annelli Sandbæk
Department of Public Health, Section for General Practice, Aarhus University, Aarhus C, Denmark
5 shared publicationsAnders Løkke
Department of Medicine, Little Belt Hospital and Department of Regional Health Research, University of Southern Denmark, Vejle, Denmark
4 shared publicationsTorsten Lauritzen
Department of Public Health, Section for General Practice, Aarhus University, Aarhus C, Denmark
4 shared publicationsAnders Helles Carlsen
Research Unit for General Practice, Aarhus University, Aarhus C, Denmark
3 shared publications- Anders Løkke
Department of Medicine, Little Belt Hospital, 7100 Vejle, Denmark
3 shared publications Bodil Hammer Bech
Department of Public Health, Section for Epidemiology, Aarhus University, Aarhus C, Denmark
3 shared publications
Latest Publications
- Open Access
- 28 April 2025
- Published by Oxford University Press (OUP) in Neuro-Oncology Practice
- Vol. 12 (5) , 912-921
Impact of the COVID-19 pandemic on referral practices for pediatric central nervous system tumors: A Danish National Comparative Cohort Study
Background: Prolonged Diagnostic Interval (DI)s pose a challenge in childhood central nervous system (CNS) tumors. The coronavirus disease 2019 (COVID-19) pandemic altered contact with healthcare. The aim of this study was to describe DIs in children diagnosed with a CNS tumor in Denmark during the first year of the pandemic. Methods: We performed a retrospective questionnaire study, mapping time intervals and symptoms in the diagnostic pathway. We analyzed DIs measured in days and performed descriptive analyses of symptoms and contacts with health care professionals (HCP). Comparison to a pre-COVID cohort was applied. Intervals were presented as total diagnostic interval (TDI; time from symptom onset to diagnosis); Patient Interval (PI; time from symptom onset to first contact to an HCP); and DI (time from first contact to an HCP to diagnosis). Results: We included 25 patients (median age 8.2 years, 56% female). Median TDI: 98 days (IQR 26 210). The DI constituted the majority of TDI (median 70 days). Low-grade tumors displayed longer TDI than high-grade tumors. No significant difference in TDI was found when compared to a pre-COVID cohort (median 98 vs. 106 days). No hesitance to contact a doctor was reported by 88%, but 24% reported delays attributable to the pandemic. Patients reported more symptoms at onset, and the trajectory in the diagnostic pathways changed with fewer patients assessed by their general practitioner than pre-COVID. Conclusions: The DI was unaltered during the COVID-19 pandemic, but changes in trajectory were reported. Results stress the ongoing need for interventions to promote timely diagnosis.
- 28 April 2025
- Published by Oxford University Press (OUP) in Neuro-Oncology Practice
- Vol. 12 (5) , 912-921
Open AccessImpact of the COVID-19 pandemic on referral practices for pediatric central nervous system tumors: A Danish National Comparative Cohort Study
Background: Prolonged Diagnostic Interval (DI)s pose a challenge in childhood central nervous system (CNS) tumors. The coronavirus disease 2019 (COVID-19) pandemic altered contact with healthcare. The aim of this study was to describe DIs in children diagnosed with a CNS tumor in Denmark during the first year of the pandemic. Methods: We performed a retrospective questionnaire study, mapping time intervals and symptoms in the diagnostic pathway. We analyzed DIs measured in days and performed descriptive analyses of symptoms and contacts with health care professionals (HCP). Comparison to a pre-COVID cohort was applied. Intervals were presented as total diagnostic interval (TDI; time from symptom onset to diagnosis); Patient Interval (PI; time from symptom onset to first contact to an HCP); and DI (time from first contact to an HCP to diagnosis). Results: We included 25 patients (median age 8.2 years, 56% female). Median TDI: 98 days (IQR 26 210). The DI constituted the majority of TDI (median 70 days). Low-grade tumors displayed longer TDI than high-grade tumors. No significant difference in TDI was found when compared to a pre-COVID cohort (median 98 vs. 106 days). No hesitance to contact a doctor was reported by 88%, but 24% reported delays attributable to the pandemic. Patients reported more symptoms at onset, and the trajectory in the diagnostic pathways changed with fewer patients assessed by their general practitioner than pre-COVID. Conclusions: The DI was unaltered during the COVID-19 pandemic, but changes in trajectory were reported. Results stress the ongoing need for interventions to promote timely diagnosis.
- 5 September 2021
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 58 (suppl 65) , PA1013
The association between lung function in adults and the socioeconomic profile in a long-term follow-up
Background: Spirometry is recommended in symptomatic smokers to identify obstructive lung diseases. However, it is unknown whether there are certain characteristics in the socioeconomic profile, which can be used to identify the individual risk of developing obstructive lung diseases. Aim: The aim of this study was to examine the association between lung function in early adulthood and socioeconomic profile through 27 years of follow-up. Method: We performed a cohort study among individuals aged 30-49 years at baseline (1991). Spirometry measurements were divided into three groups: 1: FEV1/FVC< 70, 2: FEV1/FVC: 70 - 75, 3: FEV1/FVC >75 (reference). Using negative binominal regression, socioeconomic profile was measured using yearly income and unemployment between 1991 and 2017 as a proxy. Results: A total of 905 citizens were included; mean age of 40.3 years, 47.5% were males and 51.2% were smokers at baseline. The group with a FEV1/FVC < 70 had the worst socioeconomic profile within groups as expected. The group with a FEV1/FVC< 70 had 2.04 times more registered unemployment periods after adjustment for covariates (aIRR=2.04, 95% CI 1.84; 2.26) and had a lower income (aIRR=0.93, 95% CI: 0.91; 0.97) during follow up compared to the reference group. However, the group with a FEV1/FVC: 70 - 75 also had a lower income (aIRR=0.96, 95% CI: 0.93; 0.98) and had more registered unemployment periods (aIRR=1.08, 95%CI 0.96; 1.21). Conclusion: We found an association between lung function in early adulthood and the socioeconomic profile through 27 years of follow-up. Opposite to prior studies, unemployment seemed to pose less impact in the group with a FEV1/FVC: 70 –75 than expected.
- 5 September 2021
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 58 (suppl 65) , PA1013
The association between lung function in adults and the socioeconomic profile in a long-term follow-up
Background: Spirometry is recommended in symptomatic smokers to identify obstructive lung diseases. However, it is unknown whether there are certain characteristics in the socioeconomic profile, which can be used to identify the individual risk of developing obstructive lung diseases. Aim: The aim of this study was to examine the association between lung function in early adulthood and socioeconomic profile through 27 years of follow-up. Method: We performed a cohort study among individuals aged 30-49 years at baseline (1991). Spirometry measurements were divided into three groups: 1: FEV1/FVC< 70, 2: FEV1/FVC: 70 - 75, 3: FEV1/FVC >75 (reference). Using negative binominal regression, socioeconomic profile was measured using yearly income and unemployment between 1991 and 2017 as a proxy. Results: A total of 905 citizens were included; mean age of 40.3 years, 47.5% were males and 51.2% were smokers at baseline. The group with a FEV1/FVC < 70 had the worst socioeconomic profile within groups as expected. The group with a FEV1/FVC< 70 had 2.04 times more registered unemployment periods after adjustment for covariates (aIRR=2.04, 95% CI 1.84; 2.26) and had a lower income (aIRR=0.93, 95% CI: 0.91; 0.97) during follow up compared to the reference group. However, the group with a FEV1/FVC: 70 - 75 also had a lower income (aIRR=0.96, 95% CI: 0.93; 0.98) and had more registered unemployment periods (aIRR=1.08, 95%CI 0.96; 1.21). Conclusion: We found an association between lung function in early adulthood and the socioeconomic profile through 27 years of follow-up. Opposite to prior studies, unemployment seemed to pose less impact in the group with a FEV1/FVC: 70 –75 than expected.
- 7 September 2020
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 56 (suppl 64)
Predictive value of spirometry in early detection of obstructive lung disease in adults: a cohort study
Background: Spirometry is essential to identify cases with obstructive lung diseases in primary care. However, knowledge about the long-term prognostic outcome among younger individuals is sparse. Aim: To describe the predictive value of spirometry among individuals in the age groups 30-49 (the 1991 cohort) and 45-64 (the 2006 cohort). Method: Spirometry was performed in 905 adults (30-49 years) in 1991 and in 1277 middle-aged persons (45-64 years) in 2006. The participants were categorised into three groups; FEV1/FVC < 70, 70 – 75 and >75 and followed throughout 2017 using Danish national registries. Lung disease was defined if fulfilling at least one of the following: 1) two prescriptions for respiratory medicine were redeemed within a year, 2) one lung-related contact to the hospital, 3) lung-related death. Results: In the 1991 cohort, 21% developed lung diseases and in the 2006 cohort 17% developed lung diseases throughout 2017. The probability of developing lung disease if FEV1/FVC: 70-75, was 35% (95% CI: 25% - 44%) in the 1991 cohort and 23% (95% CI: 17% - 28%) in the 2006 cohort. The positive predicted value was higher for both cohorts, when focusing on smoking history and self-reported respiratory symptoms. Conclusion: The initial spirometry has a high predictive value to identify individuals at risk of future lung diseases. In addition, the group with FEV1/FVC: 70 – 75 had a high risk of developing lung diseases later in life, suggesting this group would be a meaningful target of special interest.
- 7 September 2020
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 56 (suppl 64)
Predictive value of spirometry in early detection of obstructive lung disease in adults: a cohort study
Background: Spirometry is essential to identify cases with obstructive lung diseases in primary care. However, knowledge about the long-term prognostic outcome among younger individuals is sparse. Aim: To describe the predictive value of spirometry among individuals in the age groups 30-49 (the 1991 cohort) and 45-64 (the 2006 cohort). Method: Spirometry was performed in 905 adults (30-49 years) in 1991 and in 1277 middle-aged persons (45-64 years) in 2006. The participants were categorised into three groups; FEV1/FVC < 70, 70 – 75 and >75 and followed throughout 2017 using Danish national registries. Lung disease was defined if fulfilling at least one of the following: 1) two prescriptions for respiratory medicine were redeemed within a year, 2) one lung-related contact to the hospital, 3) lung-related death. Results: In the 1991 cohort, 21% developed lung diseases and in the 2006 cohort 17% developed lung diseases throughout 2017. The probability of developing lung disease if FEV1/FVC: 70-75, was 35% (95% CI: 25% - 44%) in the 1991 cohort and 23% (95% CI: 17% - 28%) in the 2006 cohort. The positive predicted value was higher for both cohorts, when focusing on smoking history and self-reported respiratory symptoms. Conclusion: The initial spirometry has a high predictive value to identify individuals at risk of future lung diseases. In addition, the group with FEV1/FVC: 70 – 75 had a high risk of developing lung diseases later in life, suggesting this group would be a meaningful target of special interest.
- 7 September 2020
- Published by European Respiratory Society (ERS)
- Vol. 56 (suppl 64)
The association between lung function in adults and future burden of obstructive lung diseases in a long-term follow-up
Background: Spirometry is recommended in symptomatic smokers to identify obstructive lung diseases. However, it is unknown whether there are certain characteristics, which can be used to identify the individual risk of developing obstructive lung diseases. Aim: The aim of this study was to examine the association between lung function in early adulthood and burden of lung diseases throughout 27 years of follow-up. Method: We performed a cohort study among individuals aged 30-49 years at baseline (1991). Spirometry measurements were divided into three groups: 1: FEV1/FVC< 70, 2: FEV1/FVC: 70 - 75, 3: FEV1/FVC >75 (reference). Using negative binominal regression, the burden of lung disease was measured by contacts to general practice, hospitalisations, redeemed respiratory medicine and socioeconomic parameters between 1991 and 2017. Results: A total of 905 citizens were included; mean age of 40.3 years, 47.5% were males and 51.2% were smokers at baseline. The group with a FEV1/FVC: 70 - 75 received more respiratory medicine IRR=3.37 (95% CI: 2.69 – 4.23) had a lower income IRR=0.94 (95% CI: 0.92 – 0.97) and had more contacts to their general practitioner IRR=1.14 (95% CI: 1.07 - 1.21) and hospitalisations for lung diseases IRR=2.39 (95% CI: 1.96 - 5.85) during follow up compared to the reference group. Conclusion: We found an association between lung function in early adulthood and the burden of lung diseases throughout a 27-year follow-up period. In particular, adults with a FEV1/FVC: 70 – 75 need extra attention regarding case finding.
- 7 September 2020
- Published by European Respiratory Society (ERS)
- Vol. 56 (suppl 64)
The association between lung function in adults and future burden of obstructive lung diseases in a long-term follow-up
Background: Spirometry is recommended in symptomatic smokers to identify obstructive lung diseases. However, it is unknown whether there are certain characteristics, which can be used to identify the individual risk of developing obstructive lung diseases. Aim: The aim of this study was to examine the association between lung function in early adulthood and burden of lung diseases throughout 27 years of follow-up. Method: We performed a cohort study among individuals aged 30-49 years at baseline (1991). Spirometry measurements were divided into three groups: 1: FEV1/FVC< 70, 2: FEV1/FVC: 70 - 75, 3: FEV1/FVC >75 (reference). Using negative binominal regression, the burden of lung disease was measured by contacts to general practice, hospitalisations, redeemed respiratory medicine and socioeconomic parameters between 1991 and 2017. Results: A total of 905 citizens were included; mean age of 40.3 years, 47.5% were males and 51.2% were smokers at baseline. The group with a FEV1/FVC: 70 - 75 received more respiratory medicine IRR=3.37 (95% CI: 2.69 – 4.23) had a lower income IRR=0.94 (95% CI: 0.92 – 0.97) and had more contacts to their general practitioner IRR=1.14 (95% CI: 1.07 - 1.21) and hospitalisations for lung diseases IRR=2.39 (95% CI: 1.96 - 5.85) during follow up compared to the reference group. Conclusion: We found an association between lung function in early adulthood and the burden of lung diseases throughout a 27-year follow-up period. In particular, adults with a FEV1/FVC: 70 – 75 need extra attention regarding case finding.
- Open Access
- 4 August 2020
- Published by Royal College of General Practitioners in BJGP Open
- Vol. 4 (4)
Predictive value of spirometry in early detection of lung disease in adults: a cohort study
Background: Spirometry is essential to identify cases with obstructive lung diseases (OLDs) in primary care. However, knowledge about the long-term prognostic outcome among younger individuals is sparse.Aim: To describe the predictive value of spirometry among individuals in the age groups 30–49 years and 45–64 years.Design & setting: A population-based cohort study supplied with data from Danish national registries.Method: Spirometry was performed in 905 adults aged 30–49 years in 1991 and in 1277 adults aged 45–64 years in 2006. The participants were categorised into three groups: forced expiratory volume in 1 second (FEV1)/forced vital capacity (FVC) 75. They were followed throughout 2017 using Danish national registries. Lung disease was defined as fulfilling at least one of the following: two prescriptions for respiratory medicine were redeemed within a year; one lung-related contact to the hospital; or lung-related death.Results: In the 1991 cohort, 21% developed lung diseases and in the 2006 cohort 17% developed lung diseases throughout 2017. The probability of developing lung disease if FEV1/FVC 70–75 was 35% (95% confidence interval [CI] = 25% to 44%) in the 1991 cohort and 23% (95% CI = 17% to 28%) in the 2006 cohort. The positive predicted value (PPV) was higher for both cohorts when focusing on smoking history and self-reported respiratory symptoms.Conclusion: The initial spirometry has a high predictive value to identify cases of future lung diseases. In addition, the group with FEV1/FVC 70–75 had a high risk of developing lung diseases later in life, suggesting this group would be a meaningful target of special interest.
- 4 August 2020
- Published by Royal College of General Practitioners in BJGP Open
- Vol. 4 (4)
Open AccessPredictive value of spirometry in early detection of lung disease in adults: a cohort study
Background: Spirometry is essential to identify cases with obstructive lung diseases (OLDs) in primary care. However, knowledge about the long-term prognostic outcome among younger individuals is sparse.Aim: To describe the predictive value of spirometry among individuals in the age groups 30–49 years and 45–64 years.Design & setting: A population-based cohort study supplied with data from Danish national registries.Method: Spirometry was performed in 905 adults aged 30–49 years in 1991 and in 1277 adults aged 45–64 years in 2006. The participants were categorised into three groups: forced expiratory volume in 1 second (FEV1)/forced vital capacity (FVC) 75. They were followed throughout 2017 using Danish national registries. Lung disease was defined as fulfilling at least one of the following: two prescriptions for respiratory medicine were redeemed within a year; one lung-related contact to the hospital; or lung-related death.Results: In the 1991 cohort, 21% developed lung diseases and in the 2006 cohort 17% developed lung diseases throughout 2017. The probability of developing lung disease if FEV1/FVC 70–75 was 35% (95% confidence interval [CI] = 25% to 44%) in the 1991 cohort and 23% (95% CI = 17% to 28%) in the 2006 cohort. The positive predicted value (PPV) was higher for both cohorts when focusing on smoking history and self-reported respiratory symptoms.Conclusion: The initial spirometry has a high predictive value to identify cases of future lung diseases. In addition, the group with FEV1/FVC 70–75 had a high risk of developing lung diseases later in life, suggesting this group would be a meaningful target of special interest.
- Open Access
- 26 March 2020
- Published by Springer Nature in npj Primary Care Respiratory Medicine
- Vol. 30 (1) , 1-8
Lung function in adults and future burden of obstructive lung diseases in a long-term follow-up
Spirometry is recommended in symptomatic smokers to identify obstructive lung diseases. However, it is unknown whether there are certain characteristics that can be used to identify the individual risk of developing obstructive lung diseases. The aim of this study was to examine the association between lung function in adults and burden of lung diseases throughout 27 years of follow-up. We performed a cohort study among individuals aged 30–49 years at baseline (1991). Spirometry measurements were divided into three groups: (1) FEV1/FVC < 70, (2) FEV1/FVC: 70–75, (3) FEV1/FVC > 75 (reference). Using negative binominal regression, the burden of lung diseases was measured by contacts to general practice, hospitalisations, redeemed respiratory medicine and socioeconomic parameters between 1991 and 2017. A total of 905 citizens were included; mean age of 40.3 years, 47.5% were males and 51.2% were smokers at baseline. The group with an FEV1/FVC: 70–75 received more respiratory medicine (IRR = 3.37 (95% CI: 2.69–4.23)), had lower income (IRR = 0.96 (95% CI: 0.93–0.98)), and had more contacts to general practice (IRR = 1.14 (95% CI: 1.07–1.21)) and hospitals for lung diseases (IRR = 2.39 (95% CI: 1.96–5.85)) compared to the reference group. We found an association between lung function and the future burden of lung diseases throughout 27 years of follow-up. In particular, adults with an FEV1/FVC: 70–75 need extra attention in the case finding.
- 26 March 2020
- Published by Springer Nature in npj Primary Care Respiratory Medicine
- Vol. 30 (1) , 1-8
Open AccessLung function in adults and future burden of obstructive lung diseases in a long-term follow-up
Spirometry is recommended in symptomatic smokers to identify obstructive lung diseases. However, it is unknown whether there are certain characteristics that can be used to identify the individual risk of developing obstructive lung diseases. The aim of this study was to examine the association between lung function in adults and burden of lung diseases throughout 27 years of follow-up. We performed a cohort study among individuals aged 30–49 years at baseline (1991). Spirometry measurements were divided into three groups: (1) FEV1/FVC < 70, (2) FEV1/FVC: 70–75, (3) FEV1/FVC > 75 (reference). Using negative binominal regression, the burden of lung diseases was measured by contacts to general practice, hospitalisations, redeemed respiratory medicine and socioeconomic parameters between 1991 and 2017. A total of 905 citizens were included; mean age of 40.3 years, 47.5% were males and 51.2% were smokers at baseline. The group with an FEV1/FVC: 70–75 received more respiratory medicine (IRR = 3.37 (95% CI: 2.69–4.23)), had lower income (IRR = 0.96 (95% CI: 0.93–0.98)), and had more contacts to general practice (IRR = 1.14 (95% CI: 1.07–1.21)) and hospitals for lung diseases (IRR = 2.39 (95% CI: 1.96–5.85)) compared to the reference group. We found an association between lung function and the future burden of lung diseases throughout 27 years of follow-up. In particular, adults with an FEV1/FVC: 70–75 need extra attention in the case finding.
- Open Access
- 28 August 2019
- Published by Springer Nature in BMC Public Health
- Vol. 19 (1) , 1-10
The effect on participation rates of including focused spirometry information in a health check invitation: a cluster-randomised trial in Denmark
Early detection of lung disease may help reduce disease development. Detection through preventive health checks may be beneficial. Nevertheless, the knowledge is sparse on how to enhance the participation rate in health checks among citizens at risk of developing lung disease. This study investigates if focused information on spirometry can increase the participation rate in a general health check. We conducted an open-label, household cluster-randomised trial with a two-group parallel design including 4407 citizens aged 30–49 years in Denmark and an average cluster size of 1.55 citizens per household. The control group (n = 2213) received a standard invitation describing the content of the general health check and containing practical information. The intervention group (n = 2194) received an extended invitation highlighting the benefits of early detection and prevention of lung disease. The primary outcome was difference in participation rate between the two groups. The secondary outcome was the proportion of participants at risk of lung disease in both groups. Risk profile was defined as current smoking or self-reported lung symptoms. The inclusion period was 25 November 2015–3 February 2017. No major difference in participation rate was seen between the intervention group (53.4%) and the control group (52.0%). Participants had statistically significantly higher education level compared to non-participants. A total of 24.2% of the participants were at risk of developing lung disease, but no difference was found between the intervention group and the control group. This study revealed no effect on participation rate of including focused spirometry information in the health check invitation. ClinicalTrials.gov: NCT02615769 . Registered on 25 November 2015. The trial protocol has been published.
- 28 August 2019
- Published by Springer Nature in BMC Public Health
- Vol. 19 (1) , 1-10
Open AccessThe effect on participation rates of including focused spirometry information in a health check invitation: a cluster-randomised trial in Denmark
Early detection of lung disease may help reduce disease development. Detection through preventive health checks may be beneficial. Nevertheless, the knowledge is sparse on how to enhance the participation rate in health checks among citizens at risk of developing lung disease. This study investigates if focused information on spirometry can increase the participation rate in a general health check. We conducted an open-label, household cluster-randomised trial with a two-group parallel design including 4407 citizens aged 30–49 years in Denmark and an average cluster size of 1.55 citizens per household. The control group (n = 2213) received a standard invitation describing the content of the general health check and containing practical information. The intervention group (n = 2194) received an extended invitation highlighting the benefits of early detection and prevention of lung disease. The primary outcome was difference in participation rate between the two groups. The secondary outcome was the proportion of participants at risk of lung disease in both groups. Risk profile was defined as current smoking or self-reported lung symptoms. The inclusion period was 25 November 2015–3 February 2017. No major difference in participation rate was seen between the intervention group (53.4%) and the control group (52.0%). Participants had statistically significantly higher education level compared to non-participants. A total of 24.2% of the participants were at risk of developing lung disease, but no difference was found between the intervention group and the control group. This study revealed no effect on participation rate of including focused spirometry information in the health check invitation. ClinicalTrials.gov: NCT02615769 . Registered on 25 November 2015. The trial protocol has been published.
- Open Access
- 1 December 2016
- Published by Springer Nature in Trials
- Vol. 17 (1) , 571
Effect on attendance by including focused information on spirometry in preventive health checks: study protocol for a randomized controlled trial
Early detection of lung diseases can help to reduce their severity. Lung diseases are among the most frequently occurring and serious diseases worldwide; nonetheless, many patients remain undiagnosed. Preventive health checks including spirometry can detect lung diseases at early stages; however, recruitment for health checks remains a challenge, and little is known about what motivates the attendance. The aim of the study is to examine whether focused information on spirometry in the invitation compared to general information will impact the attendance rate in preventive health checks. This randomized, controlled trial tests the effect of information on spirometry embedded in the Check your Health Preventive Program (CHPP). The CHPP is an open-label, household cluster-randomized, controlled trial offering a preventive health check to 30- to –49-year-olds in a Danish municipality from 2012 to 2017 (n = 26,216). During 2015–2016, 4356 citizens aged 30–49 years will be randomized into two groups. The intervention group receives an invitation which highlights the value and contents of spirometry as part of a health check and information about lung diseases. The comparison group receives a standard invitation containing practical information and specifies the contents of the general health check. Outcomes are (1) differences in attendance rates measured by the proportion of citizens attending each of the two study groups and (2) proportion of persons at risk defined by smoking status and self-reported lung symptoms in the study groups. The proportion of participants with abnormal spirometry assessed at the preventive health check will be compared between the two study groups. The results from the present study will inform future recruitment strategies to health checks. The developed material on content, value, and information about lung disease is feasible and transferable to other populations, making it easy to implement if effective. ClinicalTrials.gov: NCT02615769 . Registered on 25 November 2015.
- 1 December 2016
- Published by Springer Nature in Trials
- Vol. 17 (1) , 571
Open AccessEffect on attendance by including focused information on spirometry in preventive health checks: study protocol for a randomized controlled trial
Early detection of lung diseases can help to reduce their severity. Lung diseases are among the most frequently occurring and serious diseases worldwide; nonetheless, many patients remain undiagnosed. Preventive health checks including spirometry can detect lung diseases at early stages; however, recruitment for health checks remains a challenge, and little is known about what motivates the attendance. The aim of the study is to examine whether focused information on spirometry in the invitation compared to general information will impact the attendance rate in preventive health checks. This randomized, controlled trial tests the effect of information on spirometry embedded in the Check your Health Preventive Program (CHPP). The CHPP is an open-label, household cluster-randomized, controlled trial offering a preventive health check to 30- to –49-year-olds in a Danish municipality from 2012 to 2017 (n = 26,216). During 2015–2016, 4356 citizens aged 30–49 years will be randomized into two groups. The intervention group receives an invitation which highlights the value and contents of spirometry as part of a health check and information about lung diseases. The comparison group receives a standard invitation containing practical information and specifies the contents of the general health check. Outcomes are (1) differences in attendance rates measured by the proportion of citizens attending each of the two study groups and (2) proportion of persons at risk defined by smoking status and self-reported lung symptoms in the study groups. The proportion of participants with abnormal spirometry assessed at the preventive health check will be compared between the two study groups. The results from the present study will inform future recruitment strategies to health checks. The developed material on content, value, and information about lung disease is feasible and transferable to other populations, making it easy to implement if effective. ClinicalTrials.gov: NCT02615769 . Registered on 25 November 2015.